Incidence of interstitial pneumonitis in non-Hodgkin’s lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab
Crossref DOI link: https://doi.org/10.1007/s00277-017-3160-1
Published Online: 2017-10-31
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Ting
Shen, Qian
Peng, Hui
Chao, Tengfei
Zhang, Lihong
Huang, Liu
Yang, Kaixiang
Thapa, Sudip
Yu, Shiying
Jiang, Yongsheng
License valid from 2017-10-31